101048-76-4

Basic information

• Product Name: 2-FLUORO-4-FORMYL-BENZONITRILE
• Synonyms: 2-FLUORO-4-FORMYL-BENZONITRILE;4-CYANO-3-FLUOROBENZALDEHYDE;Benzonitrile, 2-fluoro-4-formyl- (9CI);2-fluoro-4-formylbenzenecarbonitrile;Benzonitrile, 2-fluoro-4-formyl-;2-Fluoro-4-formylbenzonitrile 98%;3-Fluoro-4-Cyanobenzaldehyde
• CAS NO: 101048-76-4
• Molecular Formula: C₈H₄FNO
• Molecular Weight: 149.12
• Product Categories: NITRILE;HALIDE;ALDEHYDE
• Mol File: 101048-76-4.mol
• Article Data: 23

Chemical Properties

• Melting Point: 80-84 °C(lit.)
• Boiling Point: 276.4°Cat760mmHg
• Flash Point: 121°C
• Appearance: /
• Density: 1.25g/cm³
• Vapor Pressure: 0.0048mmHg at 25°C
• Refractive Index: 1.527
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-FLUORO-4-FORMYL-BENZONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-FLUORO-4-FORMYL-BENZONITRILE(101048-76-4)
• EPA Substance Registry System: 2-FLUORO-4-FORMYL-BENZONITRILE(101048-76-4)

Safety Data

• Hazard Codes: Xn,T,Xi
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 101048-76-4(Hazardous Substances Data)

Usage

General Description

2-Fluoro-4-Formyl-Benonitrile is a specialized chemical compound that has importance in a variety of scientific and industrial applications. It is identified by the molecular formula C8H4FNO. As a chlorinated compound, it has strong electronegative properties, contributing to its reactivity. Its structural formula includes various functional groups, such as fluoride, formyl, and nitrile groups, which define its chemical behavior. This chemical compound is often used in research laboratories or in industrial manufacturing for the development of other complex compounds and substances. Precise handling and storage conditions are required due to its potentially reactive nature.

InChI:InChI=1/C8H4FNO/c9-8-3-6(5-11)1-2-7(8)4-10/h1-3,5H

Upstream product

• 176508-81-9 4-cyano-3-fluorobenzoic acid 
• 268734-34-5 2-fluoro-4-(methoxycarbonyl)benzonitrile 
• 64-17-5 ethanol 
• 1634-04-4 tert-butyl methyl ether 
• 222978-02-1 2-fluoro-4-(hydroxymethyl)benzonitrile 
• 153556-42-4 4-bromo-3-fluorobenzoic acid 
• 222978-01-0 4-bromo-3-fluorobenzyl alcohol 
• 85070-67-3 2-fluoro-4-methylbenzonitrile 
• 452-74-4 4-bromo-3-fluorotoluene 
• 222978-03-2 4-cyano-3-fluorobenzylbromide 
• 440105-58-8 α,α-dibromo-4-cyano-3-fluorotoluene 
• 557-21-1 dicyanozinc 
• 2591-86-8 N-Formylpiperidine 
• 105942-08-3 4-bromo-6-fluorobenzonitrile 

Downstream Products

• 222978-26-9 2-Fluoro-4-[hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-benzonitrile 
• 1204738-07-7 (4-(aminomethyl)-3-fluorophenyl)methanol 
• 1557038-32-0 2-fluoro-4-(hydroxyimino-methyl)-benzonitrile 
• 1008520-25-9 2-Fluoro-4-(1,5,5-trimethyl-7-oxo-4,5,6,7-tetrahydro-1H-indol-3-yl)-benzonitrile 
• 1008520-26-0 2-[(Tetrahydro-furan-2-ylmethyl)-amino]-4-(1,5,5-trimethyl-7-oxo-4,5,6,7-tetrahydro-1H-indol-3-yl)-benzonitrile 
• 1008520-27-1 2-[(Tetrahydro-furan-2-ylmethyl)-amino]-4-(1,5,5-trimethyl-7-oxo-4,5,6,7-tetrahydro-1H-indol-3-yl)-benzamide 
• 872460-01-0 [(E)-1-benzyl-4-(4-cyano-3-fluoro-phenyl)-2-oxo-but-3-enyl]-carbamic acid tert-butyl ester 
• 871709-95-4 2-fluoro-5-(5-trifluoromethyl-1H-imidazol-2-yl)-benzonitrile 
• 439660-16-9 2-methyl-propane-2-sulfinic acid [1-(4-cyano-3-fluoro-phenyl)-1-(3-methyl-3H-imidazol-4-yl)-ethyl]-amide 
• 275807-90-4 (+)-4-[1-amino-1-(3-methyl-3H-imidazol-4-yl)-ethyl]-2-fluoro-benzonitrile 
• 440105-71-5 (S)-{1-[7-[(tert-butyldiphenylsilyl)oxy]naphthalen-1-yl]-2-oxopyrrolidin-3-yl}-{2-[3-(4-cyano-3-fluorobenzyl)-3H-imidazol-4-yl]ethyl}carbamic acid tert-butyl ester 

Relevant articles and documents

Identification and Structure–Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P1)

Agonism of S1P1 receptor has been proven to be responsible for peripheral blood lymphopenia and elicts the identification of various S1P1 modulators. In this paper we described a series of oxadiazole-based S1P1 direct-acting agonists disubstituted on terminal benzene ring, with high potency for S1P1 receptor and favorable selectivity against S1P3 receptor. In addition, two representative agents named 16-3b and 16-3g demonstrated impressive efficacy in lymphocyte reduction along with reduced effect on heart rate when orally administered. Furthermore, these compounds have been shown to possess desired pharmacokinetic (PK) and physicochemical profiles. The binding mode between 16-3b and the activated S1P1 model was also studied.

Carboxylic acid compound containing diphenyl oxadiazole, and preparation method and medical application of compound

The invention relates to the field of medicinal chemistry, and particularly relates to a carboxylic acid compound (I) containing a diphenyl oxadiazole skeleton, a preparation method and pharmaceuticalpreparation of the compound, and a use of the compound

OXAZOLE AND THIAZOLE DERIVATIVES AS SELECTIVE PROTEIN KINASE INHIBITORS (C-KIT)

The present invention relates to compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, A, Q, W and X are as defined in the description. These compounds selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective native and/or mutant c-kit inhibitors.